F Grumbach
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 23
-
- Mycobacterium research and diagnosis 10
-
- Pharmacological Effects of Natural Compounds 4
-
- Diagnosis and treatment of tuberculosis 5
- Infectious Diseases and Tuberculosis 3
-
- Synthesis and Characterization of Heterocyclic Compounds 4
- Synthesis and biological activity 3
-
- Cancer therapeutics and mechanisms 3
- Journals
- Ann. Inst. Pasteur (2 papers)PubMed (27 papers)Tubercle (6 papers)
- Partner nations
- France
In The Last Decade
F Grumbach
32 papers receiving 212 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 222
- Epidemiology 172
- Pharmacology 28
- Molecular Medicine 10
- Surgery 87
Countries citing papers authored by F Grumbach
This map shows the geographic impact of F Grumbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Grumbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Grumbach more than expected).
Fields of papers citing papers by F Grumbach
This network shows the impact of papers produced by F Grumbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Grumbach. The network helps show where F Grumbach may publish in the future.
Co-authorship network
The 8 scholars most cited alongside F Grumbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test]. | 1970 | 4 |
| 2 | [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice]. | 1969 | 1 |
| 3 | 1969 | 64 | |
| 4 | 1968 | 7 | |
| 5 | [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse]. | 1968 | 1 |
| 6 | [Tuberculosis bacilli of the African type: preliminary note]. | 1968 | 44 |
| 7 | 1967 | 19 | |
| 8 | Antituberculous Activity in Mice of Ethambutol (Dextro-2,2'-Ethylenediimino) di-iButanol Associated with Isoniazid and Ethionamide. | 1966 | 1 |
| 9 | Study of virulence in guinea pigs of mycobacterium tuberculosis strains from the Republic of Madagascar. Comparison of their virulence in guinea pigs and mice. | 1966 | 1 |
| 10 | [Chemotherapeutic studies on advanced tuberculosis in mice]. | 1965 | 4 |
| 11 | Experimental basis for the chemotherapy of tuberculosis. | 1965 | 3 |
| 12 | [The S-oxide of gamma-ethylthioisonicotinamide]. | 1963 | 2 |
| 13 | 1962 | 6 | |
| 14 | [Experimental antituberculous activity of 2 derivatives of pigmented phenazine (B 663 and B 720) alone and combined with other antitubercular agents (Isoniazid and ethoniamide)]. | 1960 | 1 |
| 15 | 1960 | 9 | |
| 16 | Experimental Antituberculous Activity of Pyrazinamide (PZA). | 1958 | 1 |
| 17 | [Tuberculous infection of the mouse involves its resistance to experimental plague infection]. | 1958 | 4 |
| 18 | [Relationship between the chemical constitution and tuberculostatic activity of substituted isonicotinic thioamides]. | 1957 | 0 |
| 19 | [Pathogenic power of isoniazid resistant Mycobacterium tuberculosis]. | 1955 | 1 |
| 20 | [A new derivative of PAS, phenyl paraaminosalicylate or FR7; tuberculostatic activity in vitro and in the mouse]. | 1951 | 2 |
About F Grumbach
F Grumbach is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Molecular Medicine and Pharmacology, having authored 36 papers that have together received 304 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (23 papers), Mycobacterium research and diagnosis (10 papers), Diagnosis and treatment of tuberculosis (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Cancer therapeutics and mechanisms (3 papers), Infectious Diseases and Tuberculosis (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Infectious Diseases (222 citations), Epidemiology (172 citations), Pharmacology (28 citations), Molecular Medicine (10 citations) and Surgery (87 citations). F Grumbach has collaborated with scholars based in France. Frequent co-authors include G Canetti, N Rist, J Grosset, G Biozzi, Baruj Benacerraf, Halpern Bn, G. Girard and J. Grosset. Their work appears in journals such as Ann. Inst. Pasteur, PubMed and Tubercle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.